Year |
Citation |
Score |
2024 |
Shi Y, Reker D, Byrne JD, Kirtane AR, Hess K, Wang Z, Navamajiti N, Young CC, Fralish Z, Zhang Z, Lopes A, Soares V, Wainer J, von Erlach T, Miao L, et al. Screening oral drugs for their interactions with the intestinal transportome via porcine tissue explants and machine learning. Nature Biomedical Engineering. PMID 38378821 DOI: 10.1038/s41551-023-01128-9 |
0.444 |
|
2023 |
Li Y, Lee JS, Kirtane AR, Li M, Iii CWC, Hess K, Lopes A, Collins J, Tamang S, Ishida K, Hayward A, Wainer J, Wentworth AJ, Traverso G. Enzyme-Triggered Intestine-Specific Targeting Adhesive Platform For Universal Oral Drug Delivery. Advanced Healthcare Materials. e2301033. PMID 37314859 DOI: 10.1002/adhm.202301033 |
0.358 |
|
2023 |
Chen CL, Hernandez JC, Uthaya Kumar DB, Machida T, Tahara SM, El-Khoueiry A, Li M, Punj V, Swaminathan SK, Kirtane A, Chen Y, Panyam J, Machida K. Profiling of Circulating Tumor Cells for Screening of Selective Inhibitors of Tumor-Initiating Stem-Like Cells. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2206812. PMID 36949364 DOI: 10.1002/advs.202206812 |
0.628 |
|
2022 |
Kirtane AR, Karavasili C, Wahane A, Freitas D, Booz K, Le DTH, Hua T, Scala S, Lopes A, Hess K, Collins J, Tamang S, Ishida K, Kuosmanen JLP, Rajesh NU, et al. Development of oil-based gels as versatile drug delivery systems for pediatric applications. Science Advances. 8: eabm8478. PMID 35622910 DOI: 10.1126/sciadv.abm8478 |
0.394 |
|
2021 |
Reker D, Rybakova Y, Kirtane AR, Cao R, Yang JW, Navamajiti N, Gardner A, Zhang RM, Esfandiary T, L'Heureux J, von Erlach T, Smekalova EM, Leboeuf D, Hess K, Lopes A, et al. Computationally guided high-throughput design of self-assembling drug nanoparticles. Nature Nanotechnology. PMID 33767382 DOI: 10.1038/s41565-021-00870-y |
0.478 |
|
2021 |
Kirtane AR, Verma M, Karandikar P, Furin J, Langer R, Traverso G. Nanotechnology approaches for global infectious diseases. Nature Nanotechnology. 16: 369-384. PMID 33753915 DOI: 10.1038/s41565-021-00866-8 |
0.354 |
|
2020 |
Li J, Wang T, Kirtane AR, Shi Y, Jones A, Moussa Z, Lopes A, Collins J, Tamang SM, Hess K, Shakur R, Karandikar P, Lee JS, Huang HW, Hayward A, et al. Gastrointestinal synthetic epithelial linings. Science Translational Medicine. 12. PMID 32848090 DOI: 10.1126/Scitranslmed.Abc0441 |
0.381 |
|
2020 |
Reker D, Shi Y, Kirtane AR, Hess K, Zhong GJ, Crane E, Lin CH, Langer R, Traverso G. Machine Learning Uncovers Food- and Excipient-Drug Interactions. Cell Reports. 30: 3710-3716.e4. PMID 32187543 DOI: 10.1016/J.Celrep.2020.02.094 |
0.478 |
|
2019 |
Kong YL, Zou X, McCandler CA, Kirtane AR, Ning S, Zhou J, Abid A, Jafari M, Rogner J, Minahan D, Collins JE, McDonnell S, Cleveland C, Bensel T, Tamang S, et al. 3D-Printed Gastric Resident Electronics. Advanced Materials Technologies. 4: 1800490. PMID 32010758 DOI: 10.1002/Admt.201800490 |
0.691 |
|
2019 |
Kirtane AR, Hua T, Hayward A, Bajpayee A, Wahane A, Lopes A, Bensel T, Ma L, Stanczyk FZ, Brooks S, Gwynne D, Wainer J, Collins J, Tamang SM, Langer R, et al. A once-a-month oral contraceptive. Science Translational Medicine. 11. PMID 31801885 DOI: 10.1126/Scitranslmed.Aay2602 |
0.677 |
|
2019 |
Khanna V, Kalscheuer S, Kirtane A, Zhang W, Panyam J. Perlecan-targeted nanoparticles for drug delivery to triple-negative breast cancer. Future Drug Discovery. 1: FDD8. PMID 31448368 DOI: 10.4155/fdd-2019-0005 |
0.61 |
|
2019 |
Liu G, Khanna V, Kirtane A, Grill A, Panyam J. Chemopreventive efficacy of oral curcumin: a prodrug hypothesis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201900166R. PMID 31136203 DOI: 10.1096/Fj.201900166R |
0.609 |
|
2019 |
Babaee S, Pajovic S, Kirtane AR, Shi J, Caffarel-Salvador E, Hess K, Collins JE, Tamang S, Wahane AV, Hayward AM, Mazdiyasni H, Langer R, Traverso G. Temperature-responsive biometamaterials for gastrointestinal applications. Science Translational Medicine. 11. PMID 30996082 DOI: 10.1126/Scitranslmed.Aau8581 |
0.467 |
|
2018 |
Altreuter D, Kirtane AR, Grant T, Kruger C, Traverso G, Bellinger A. Changing the pill: developments towards the promise of an ultra long-acting gastroretentive dosage form. Expert Opinion On Drug Delivery. PMID 30392404 DOI: 10.1080/17425247.2018.1544615 |
0.357 |
|
2018 |
Hayward A, Bensel T, Mazdiyasni H, Rogner J, Kirtane AR, Lee YL, Hua T, Bajpayee A, Collins J, McDonnell S, Cleveland C, Lopes A, Wahane A, Langer R, Traverso G. Scalable Gastric Resident Systems for Veterinary Application. Scientific Reports. 8: 11816. PMID 30087406 DOI: 10.1038/S41598-018-30212-3 |
0.714 |
|
2018 |
Shankar GM, Kirtane AR, Miller JJ, Mazdiyasni H, Rogner J, Tai T, Williams EA, Higuchi F, Juratli TA, Tateishi K, Koerner MVA, Tummala SS, Fink AL, Penson T, Schmidt SP, et al. Genotype-targeted local therapy of glioma. Proceedings of the National Academy of Sciences of the United States of America. PMID 30082399 DOI: 10.1073/Pnas.1805751115 |
0.459 |
|
2018 |
Traverso G, Kirtane AR, Schoellhammer CM, Langer R. Convergence for Translation: Drug-Delivery Research in Multidisciplinary Teams. Angewandte Chemie (International Ed. in English). PMID 29520902 DOI: 10.1002/Anie.201712512 |
0.501 |
|
2018 |
Kirtane AR, Abouzid O, Minahan D, Bensel T, Hill AL, Selinger C, Bershteyn A, Craig M, Mo SS, Mazdiyasni H, Cleveland C, Rogner J, Lee YL, Booth L, Javid F, et al. Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy. Nature Communications. 9: 2. PMID 29317618 DOI: 10.1038/S41467-017-02294-6 |
0.465 |
|
2018 |
Traverso G, Kirtane AR, Schoellhammer CM, Langer R. Translation durch Konvergenz: Drug-Delivery-Forschung in multidisziplinären Teams Angewandte Chemie. 130: 4226-4234. DOI: 10.1002/Ange.201712512 |
0.515 |
|
2017 |
Liu J, Pang Y, Zhang S, Cleveland C, Yin X, Booth L, Lin J, Lucy Lee YA, Mazdiyasni H, Saxton S, Kirtane AR, Erlach TV, Rogner J, Langer R, Traverso G. Triggerable tough hydrogels for gastric resident dosage forms. Nature Communications. 8: 124. PMID 28743858 DOI: 10.1038/S41467-017-00144-Z |
0.527 |
|
2017 |
Song JM, Molla K, Anandharaj A, Cornax I, O Sullivan MG, Kirtane AR, Panyam J, Kassie F. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling. Oncotarget. 8: 26927-26940. PMID 28460475 DOI: 10.18632/Oncotarget.15879 |
0.575 |
|
2017 |
Kirtane AR, Rothenberger MK, Frieberg A, Nephew K, Schultz-Darken N, Schmidt T, Reimann T, Schlievert P, Haase AT, Panyam J. Evaluation of vaginal drug levels and safety of a locally administered glycerol monolaurate cream in rhesus macaques. Journal of Pharmaceutical Sciences. PMID 28389267 DOI: 10.1016/J.Xphs.2017.03.030 |
0.624 |
|
2017 |
Kirtane AR, Sadhukha T, Kim H, Khanna V, Koniar B, Panyam J. Fibrinolytic enzyme co-therapy improves tumor perfusion and therapeutic efficacy of anticancer nanomedicine. Cancer Research. PMID 28108516 DOI: 10.1158/0008-5472.Can-16-1646 |
0.64 |
|
2017 |
Khanna V, Kalscheuer S, Kirtane A, Panyam J. Abstract 2181: Antibody-conjugated nanoparticles for targeting metastatic triple-negative breast cancer Cancer Research. 77: 2181-2181. DOI: 10.1158/1538-7445.Am2017-2181 |
0.641 |
|
2016 |
Siegel RA, Kirtane AR, Panyam J. Assessing the benefits of targeted drug delivery by nanocarriers: A partico/pharmacokinetic framework. Ieee Transactions On Bio-Medical Engineering. PMID 27913319 DOI: 10.1109/Tbme.2016.2632733 |
0.715 |
|
2016 |
Kirtane AR, Langer R, Traverso G. Progress in Formulation-Based Approaches for Antiretrovirals. Journal of Pharmaceutical Sciences. PMID 27771050 DOI: 10.1016/J.Xphs.2016.09.015 |
0.545 |
|
2016 |
Song JM, Anandharaj A, Upadhyaya P, Kirtane AR, Kim JH, Hong KH, Panyam J, Kassie F. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors. Oncotarget. PMID 27458163 DOI: 10.18632/Oncotarget.10759 |
0.58 |
|
2016 |
Chen C, Swaminathan S, Kirtane A, Panyam J, Machida K. Abstract 4657: Selective inhibitors epigenetically modify and eradicate tumor-initiating stem-like cells through downregulating microRNA 22-mediated TET induction and apoptosis Cancer Research. 76: 4657-4657. DOI: 10.1158/1538-7445.Am2016-4657 |
0.641 |
|
2016 |
Kirtane AR, Narayan P, Liu G, Panyam J. Polymer-surfactant nanoparticles for improving oral bioavailability of doxorubicin Journal of Pharmaceutical Investigation. 47: 65-73. DOI: 10.1007/S40005-016-0293-5 |
0.655 |
|
2015 |
Kirtane AR, Wong HL, Guru BR, Lis LG, Georg GI, Gurvich VJ, Panyam J. Reformulating tylocrebrine in EGFR targeted polymeric nanoparticles improves its therapeutic index. Molecular Pharmaceutics. PMID 26065924 DOI: 10.1021/Acs.Molpharmaceut.5B00173 |
0.7 |
|
2015 |
Kirtane AR, Siegel RA, Panyam J. A pharmacokinetic model for quantifying the effect of vascular permeability on the choice of drug carrier: a framework for personalized nanomedicine. Journal of Pharmaceutical Sciences. 104: 1174-86. PMID 25583443 DOI: 10.1002/Jps.24302 |
0.702 |
|
2014 |
Song JM, Kirtane AR, Upadhyaya P, Qian X, Balbo S, Teferi F, Panyam J, Kassie F. Intranasal delivery of liposomal indole-3-carbinol improves its pulmonary bioavailability. International Journal of Pharmaceutics. 477: 96-101. PMID 25311179 DOI: 10.1016/J.Ijpharm.2014.10.018 |
0.601 |
|
2014 |
Usacheva M, Swaminathan SK, Kirtane AR, Panyam J. Enhanced photodynamic therapy and effective elimination of cancer stem cells using surfactant-polymer nanoparticles. Molecular Pharmaceutics. 11: 3186-95. PMID 25061685 DOI: 10.1021/Mp5003619 |
0.609 |
|
2014 |
Arora S, Swaminathan SK, Kirtane A, Srivastava SK, Bhardwaj A, Singh S, Panyam J, Singh AP. Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer therapy. International Journal of Nanomedicine. 9: 2933-42. PMID 24971005 DOI: 10.2147/Ijn.S61949 |
0.579 |
|
2014 |
Kirtane AR, Wiedmann T, Panyam J. Abstract 4466: Surface-functionalized nanoparticles for inhalation delivery of chemotherapeutics to lung cancer Cancer Research. 74: 4466-4466. DOI: 10.1158/1538-7445.Am2014-4466 |
0.649 |
|
2013 |
Kirtane AR, Panyam J. Polymer nanoparticles: Weighing up gene delivery. Nature Nanotechnology. 8: 805-6. PMID 24202534 DOI: 10.1038/Nnano.2013.234 |
0.6 |
|
2013 |
Kirtane AR, Kalscheuer SM, Panyam J. Exploiting nanotechnology to overcome tumor drug resistance: Challenges and opportunities. Advanced Drug Delivery Reviews. 65: 1731-47. PMID 24036273 DOI: 10.1016/J.Addr.2013.09.001 |
0.673 |
|
2012 |
Roger E, Kalscheuer S, Kirtane A, Guru BR, Grill AE, Whittum-Hudson J, Panyam J. Folic acid functionalized nanoparticles for enhanced oral drug delivery. Molecular Pharmaceutics. 9: 2103-10. PMID 22670575 DOI: 10.1021/Mp2005388 |
0.647 |
|
Show low-probability matches. |